Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease

Ann Pharmacother. 2022 Mar 18:10600280221080986. doi: 10.1177/10600280221080986. Online ahead of print.
No abstract available

Publication types

  • Letter